InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
82.77
(
0.00%
)
Bitcoin
63,791.84
(
-0.16%
)
Post# of 251720
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

DewDiligence

Send PM Follow Ignore
Followers 826
Posts 119569
Boards Moderated 14
Alias Born 09/05/2002

DewDiligence

Member Level

Re: biotech jim post# 200831

Tuesday, 03/14/2017 6:16:48 PM

Tuesday, March 14, 2017 6:16:48 PM

Post# of 251720
MRK—FDA grants accelerated approval for Keytruda in r/r classical Hodgkin lymphoma:

http://finance.yahoo.com/news/fda-approves-merck-keytruda-pembrolizumab-210500792.html

This is Keytruda’s first approval in a blood cancer. The PDUFA date was 3/17/17.

BMY’s Opdivo received accelerated approval for a slightly different (but effectively the same) indication in May 2016 (#msg-122707413).

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up